HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Ltd
Previous close
$20.33
Day range
$20.02 - $20.38
Year range
$13.02 - $22.09
Market cap
1.44B USD
Avg Volume
388.77K
P/E ratio
237.79
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 79.86M | 65.18% |
Operating expense | 65.02M | 47.04% |
Net income | -17.70M | -44.29% |
Net profit margin | -22.17 | 12.65% |
Earnings per share | -0.25 | -38.89% |
EBITDA | -16.08M | -51.66% |
Effective tax rate | -24.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 213.55M | 13.90% |
Total assets | 519.67M | 17.34% |
Total liabilities | 87.78M | 66.35% |
Total equity | 431.90M | — |
Shares outstanding | 70.94M | — |
Price to book | 3.33 | — |
Return on assets | -7.91% | — |
Return on capital | -9.24% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -17.70M | -44.29% |
Cash from operations | 3.99M | 193.44% |
Cash from investing | 25.52M | 167.31% |
Cash from financing | 3.61M | 3,914.44% |
Net change in cash | 33.12M | 178.68% |
Free cash flow | 10.66M | 522.11% |
About
Founded
2015
Website
Employees
297